Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

  1. Kineret

Descriptions


Anakinra injection is used alone or together with other medicines to treat signs and symptoms of moderately to severely active rheumatoid arthritis in patients who have previously received other medicines (eg, DMARDs) that did not work well.

Anakinra injection is also used to treat a rare genetic disorder called neonatal-onset multisystem inflammatory disease (NOMID). NOMID is the most severe form of a condition called cryopyrin-associated periodic syndrome (CAPS).

Anankira injection is also used to treat deficiency of interleukin-1 receptor antagonist (DIRA).

Anankira injection is also used to treat coronavirus disease 2019 (COVID-19) in patients with positive results of direct SARS-CoV-2 testing with pneumonia requiring supplemental oxygen, who are at high risk for progression to severe respiratory failure and likely to have a blood problem.

This medicine is available only with your doctor's prescription (for rheumatoid arthritis, NOMID, and DIRA) or given only by or under the immediate supervision of your doctor (for COVID-19).

This product is available in the following dosage forms:

  • Solution

From Mayo Clinic to your inbox

Sign up for free, and stay up to date on research advancements, health tips and current health topics, like COVID-19, plus expertise on managing health. Click here for an email preview.

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.

Portions of this document last updated: Feb. 01, 2023

Copyright: © Merative US L.P. 1973, 2023. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.